Tag

Affibody

Affibody and partners announce positive Phase 2 results

May 4, 2022

Affibody, Acelyrin and Inmagene Biopharmaceuticals …

Loskog and Bejker

Affibody and Lokon Pharma initiate collaboration

January 12, 2022

Lokon Pharma has announced a …

Nikolai Brun

Affibody and partners announce positive trial results

December 15, 2021

Affibody, ACELYRIN, and Inmagene Biopharmaceuticals, …

Affibody enters agreement with Acelyrin

November 17, 2021

Affibody has announced a partnership …

David Bejker

Affibody and Inmagene announce IND Clearance

March 10, 2021

The US FDA has cleared …

Fredrik Frejd

Affibody and Inmagene announce IND Clearance

February 10, 2021

Affibody and Inmagene Biopharmaceuticals has …

Biovian

Affibody selects Biovian as a CDMO partner for ABY-062

February 9, 2021

Affibody has selected Biovian Oy …

Fredrik Frejd

Affibody terminates program and announces positive data from another

June 15, 2020

Affibody has announced the completion …

David Bejker

Affibody enters partnership with Inmagene

May 15, 2020

Under the terms of the …

David Bejker

Affibody announces Option Exercise by Daewoong

May 4, 2020

Affibody has announced that its …

David Bejker

Affibody and GE Healthcare to collaborate

September 20, 2019

Affibody has announced a strategic …

David Bejker

Affibody announces interim analysis in Phase 2 Psoriasis trial

August 11, 2019

The company has completed a …

Affibody agreement 3P

Affibody in agreement with 3P Biopharmaceuticals

May 27, 2019

The agreement with 3P Biopharmaceuticals …

David Bejker

Affibody announces co-development agreement with Alexion

March 20, 2019

Swedish Affibody and US Alexion …

affibody_lab

Affibody to initiate phase II psoriasis trial

May 12, 2017

Affibody announces that it has …

Nanovector, Affibody to Collaborate

Ellen R. Delisio

December 5, 2014

Norway’s Nordic Nanovector ASA and …

1
2